Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.
VCAR has a new ticker in TESL. ETF utilizes a dynamic active management approach to capture the potential of Tesla’s stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback